FDA approves Spark’s gene therapy for rare blindness pioneered at CHOP – Philly.com
|
FDA approves Spark's gene therapy for rare blindness pioneered at CHOP
Philly.com The treatment, developed by Philadelphia drug maker Spark Therapeutics and researchers at Children's Hospital of Philadelphia, and represents the first gene therapy for a genetic disease in the United States. “Today's approval marks another first in … |
